Why this Peninsula drug maker's stock soared 40% higher today

The company is asking the FDA to approve the same drug as a treatment for prostate cancer and for uterine fibroids.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.